Mirtazapine interactions with monoamine oxidase: a systematic review

被引:0
|
作者
Guinovart, M. [1 ]
Guinovart, A. [2 ]
Cardoner Alvarez, N. [1 ]
Monreal, J. A. [1 ]
Palao Vidal, D. [1 ]
机构
[1] Autonomous Univ Barcelona UAB, Parc Tauli Univ Hosp, I3PT, CIBERSAM,Dept Mental Hlth, Sabadell, Spain
[2] Miguel Servet Univ Hosp, Dept Clin Neurophysiol, Zaragoza, Spain
关键词
Monoamine oxidase; Mirtazapine; psychopharmacology; interactions;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
EPV1051
引用
收藏
页码:S484 / S485
页数:2
相关论文
共 50 条
  • [1] Monoamine Oxidase Interactions
    Shader, Richard I.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2023, 43 (04) : 394 - 394
  • [2] The interactions of caffeine with monoamine oxidase
    Petzer, Anel
    Pienaar, Anke
    Petzer, Jacobus P.
    LIFE SCIENCES, 2013, 93 (07) : 283 - 287
  • [3] THE INTERACTIONS OF MILACEMIDE WITH MONOAMINE-OXIDASE
    OBRIEN, EM
    TIPTON, KF
    MCCRODDEN, JM
    YOUDIM, MBH
    BIOCHEMICAL PHARMACOLOGY, 1994, 47 (04) : 617 - 623
  • [4] INTERACTIONS WITH MONOAMINE-OXIDASE INHIBITORS
    MCQUEEN, EG
    BRITISH MEDICAL JOURNAL, 1975, 4 (5988): : 101 - 101
  • [5] INTERACTIONS WITH MONOAMINE-OXIDASE INHIBITORS
    MCGILCHRIST, JM
    BRITISH MEDICAL JOURNAL, 1975, 3 (5983): : 591 - 592
  • [6] Monoamine oxidase inhibitors - An update on drug interactions
    Livingston, MG
    Livingston, HM
    DRUG SAFETY, 1996, 14 (04) : 219 - 227
  • [7] INTERACTIONS OF MONOAMINE-OXIDASE WITH SUBSTRATES AND INHIBITORS
    DOSTERT, PL
    BENEDETTI, MS
    TIPTON, KF
    MEDICINAL RESEARCH REVIEWS, 1989, 9 (01) : 45 - 89
  • [8] Monoamine Oxidase Inhibitors and Neuroprotection: A Review
    Al-Nuaimi, Saleem K.
    MacKenzie, Erin M.
    Baker, Glen B.
    AMERICAN JOURNAL OF THERAPEUTICS, 2012, 19 (06) : 436 - 448
  • [9] MONOAMINE-OXIDASE INHIBITORS - A REVIEW
    TOLLEFSON, GD
    JOURNAL OF CLINICAL PSYCHIATRY, 1983, 44 (08) : 280 - 288
  • [10] Mirtazapine in pregnancy and lactation - A systematic review
    Smit, Mirte
    Dolman, Koert M.
    Honig, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (01) : 126 - 135